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Abstract
Objective: To characterize baseline canine lymphocyte phenotypes including lymphocytes coexpressing
multiple markers by novel 7-color multiparameter flow cytometry. Study Design: Fresh canine peripheral
blood lymphocytes of 79 healthy 26-week-old Beagle or Beagle-mix dogs were stained and analyzed. Results:
The high number of samples and acquired flow data (averaging 1.9x105 cells/sample) allowed the detection of
minor lymphocyte subsets coexpressing multiple lymphocyte markers. The averaged percentages of major
lymphocyte subsets of CD3+, CD4+, CD8+, CD21+ and gd TCR+ cells from this study were 74.0, 43.6, 14.3,
9.6, and 0.2, respectively, which were comparable but uniquely different from other reports as they were
simultaneously detected in the same sample. We demonstrated that the commonly used CD21 and CD3
monoclonal antibody (mAb) clones, previously recommended not to be used in the same staining, could and
should be used together with the proper steps of lymphocyte gating. We found a high percentage (10.3%) of
unidentified CD21–CD3+CD4–CD8–gdTCR– lymphocyte subset that has never been reported. The
intensive gating strategy and the mean percentages of each lymphocyte subset to their parent subsets and to
the total lymphocyte population are presented and discussed. Conclusion: The canine lymphocyte
phenotypes were fully characterized. This novel multiparameter flow cytometry method is a powerful
approach to in-crease the accuracy of lymphocyte phenotyping in dogs.
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OBJECTIVE: To characterize baseline canine lympho-
cyte phenotypes including lymphocytes coexpressing
multiple markers by novel 7-color multiparameter flow
cytometry.
STUDY DESIGN: Fresh canine peripheral blood lym-
phocytes of 79 healthy 26-week-old Beagle or Beagle-mix
dogs were stained and analyzed.
RESULTS: The high number of samples and acquired
flow data (averaging 1.9 × 105 cells/sample) allowed the
detection of minor lymphocyte subsets coexpressing 
multiple lymphocyte markers. The averaged percentages
of major lymphocyte subsets of CD3+, CD4+, CD8+,
CD21+ and γ δ TCR+ cells from this study were 74.0,
43.6, 14.3, 9.6, and 0.2, respectively, which were com-
parable but uniquely different from other reports as they
were simultaneously detected in the same sample. We
demonstrated that the commonly used CD21 and CD3
monoclonal antibody (mAb) clones, previously recom-
mended not to be used in the same staining, could and
should be used together with the proper steps of lym-
phocyte gating. We found a high percentage (10.3%) of
unidentified CD21– CD3+ CD4– CD8– γ δ TCR– lym-
phocyte subset that has never been reported. The inten-
sive gating strategy and the mean percentages of each
lymphocyte subset to their parent subsets and to the total
lymphocyte population are presented and discussed.
CONCLUSION: The canine lymphocyte phenotypes
were fully characterized. This novel multiparameter flow
cytometry method is a powerful approach to in-crease the
accuracy of lymphocyte phenotyping in dogs. (Anal
Quant Cytopathol Histopathol 2013;35:197–204)
Keywords: Beagle dog, canine diseases, canine
lymphocytes, flow cytometry, lymphocyte pheno-
typing.
The characterization of lymphocyte subset distribu-
tion in clinically normal dogs provides the basis 
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to study any changes in dogs affected by infectious
agents, neoplasia, or other pathologic conditions.
The phenotyping of canine lymphocytes by flow 
cytometer has been done in various breeds,1,2 age
groups,1-7 and clinical conditions.2,8,9 Most of these
studies were performed using single-color,1,2,4,6
dual-color,2,7,10 or triple-color7,10 flow cytometry.
The limited availability of monoclonal antibodies
(mAbs) specific to canine lymphocyte markers 
restricts the subsets, which may be analyzed. When
primary mAbs of identical isotype are used, it re-
quires direct conjugation with compatible fluoro-
chromes to use them concurrently. Cross-reaction
of specific mAbs among different species helps 
expand the pools of compatible mAbs. Faldyna et
al11 characterized a panel of commercially available
mAbs specific to human lymphocytes. They con-
firmed 3 clones of anti-human CD21 that stained 
canine CD21 the same way as an anti-canine CD21
clone and could be used as alternatives, but all of
them were the same mouse IgG1 isotype.
This study utilized commercially available di-
rectly conjugated mAbs as well as unconjugated
mAbs with their corresponding secondary con-
jugates to develop a compatible 7-color multipa-
rameter flow cytometry protocol to identify the 
phenotypes of canine peripheral blood lympho-
cytes (PBLs), the coexpression of multiple lympho-
cyte markers, and their distribution in relation to
each other. The intensive gating strategy and the
mean percentages of each lymphocyte subset to
their parent subsets and to the total lymphocyte
population are presented and discussed.
Materials and Methods
Animals
The same 79 healthy Beagle or Beagle-mix breed
dogs at 26 weeks of age used in a study to evaluate
the T cell responses induced by various canine vac-
cines were used in this study. All dogs were born
within a 1-week period, vaccinated with various
routine canine vaccines, and handled under the
Code of Federal Regulations (9 CFR 3.6.C) and 
Institutional Animal Care and Use Committee 
approved protocol (#RD11-090, 9/16/11). The data
presented here were on fresh peripheral blood
mononuclear cells (PBMCs) from all dogs regard-
less of the vaccines they received.
Blood Samples
Blood samples (7 mL) were collected in Vacutainer
cell preparation tubes with sodium citrate as anti-
coagulant and Ficoll as density gradient separation
solution (BD Diagnostics, Franklin Lakes, New 
Jersey, U.S.A.). The blood tubes were centrifuged 
at 1,500× g for 25 minutes at room temperature 
(RT) within 1 hour after blood collection to separate
PBMCs from whole blood.
Multiparameter Flow Cytometry
PBMC Isolation. The PBMCs used in this study
were from the same PBMC population isolated to
evaluate the T cell responses induced by various 
canine vaccines in another study. The PBMCs were
collected from the cell preparation tubes, and red
blood cells were lysed by adding 6 mL of buffered
water (0.15 M Na2HPO4 and 0.15 M KH2PO4) for 1
minute followed by 3 mL of 3× PBS. The pellets
were washed once with 10 mL PBS then resuspend-
ed in RPMI++ (RPMI 1640 with L-glutamine and 
25 mM HEPES, supplemented with 15% fetal bo-
vine serum (Atlanta Biologicals, Norcross, Georgia,
U.S.A.), penicillin (150 IU/mL)/streptomycin (150
μg/mL)/amphotericin B (0.38 μg/mL) solution
(Mediatech, Inc., Herndon, Virginia, U.S.A.), and
1.5 μg/mL gentamicin (Invitrogen, Grand Island,
New York, U.S.A.). The cells in PBMC suspensions
were counted and adjusted to 5 × 106 cells/mL with
RPMI++.
Antibody Panels. The details of specific primary an-
tibodies and secondary antibody conjugates used in
this study are listed in Table I.
PBL Staining. A total of 200 μL of each PBMC sus-
pension with 106 cells were added in each well of a
96-well, flat-bottomed tissue culture microtitration
plate. After 2 hours’ incubation at 37°C most mono-
cytes attached to the bottom of the plate. The unat-
tached PBLs were transferred to a 96-well, round-
bottomed tissue culture microtitration plate. The
plate was centrifuged at 800× g for 1 minute and the
supernatant was removed by rapid flicking of the
plate in all washing steps. The PBLs were washed
once with PBS++ (PBS with 0.5% bovine serum al-
bumin and 0.1% sodium azide). The primary anti-
body mix was added to all wells (50 μL), the cells 
resuspended, and the plate was incubated at RT for
30 minutes. After incubation the plate was washed
twice with PBS++. All wells then received 50 μL of
the secondary antibody mix, the cells were resus-
pended, and the plate was incubated at RT for an-
other 30 minutes and washed 3 times with PBS++.
The 1% solution of ultrapure formaldehyde (Poly-
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science, Warrington, Pennsylvania, U.S.A.) in PBS
was added to all wells (250 μL) before transferred 
to flow tubes (BD Biosciences, San Jose, California,
U.S.A.). The tubes were stored at 4°C until analyzed
within 1 day.
Flow Cytometry Analysis. The personnel of the Flow
Cytometry Facility of the Office of Biotechnology,
Iowa State University, acquired the data from the
stained PBLs by a cytometer (FACSCanto, BD Bio-
sciences). The 2 lasers 488 nm Argon and 633 nm
HeNe were used. The 488 nm Argon laser excited 5
fluorochromes: FITC, PE, DyeMer 488/615, PE-
Cy5.5 and PE-Cy7 using filters 530/30, 575/26,
610/20, 695/40 and 780/60, respectively. The 633
nm HeNe laser excited 2 fluorochromes: efluor 660
and AlexaFluor 700 using filters 660/20 and 730/
45, respectively. The averaged total acquisition was
1.9 × 105 cells/sample.
Flow Data Analysis. The cell analysis software
FlowJo version 9.3.2 (Tree Star Inc., Ashland, Ore-
gon, U.S.A.) was used to analyze the flow cytome-
try data. All plots mentioned here are from Figure
1. From all PBLs the single cells were gated on for-
ward scatter–height and forward scatter–area plot
(plot A1) to eliminate doublet cells. The lympho-
cytes1,4,12 were then gated on side scatter–area and
forward scatter–area plot (plot A2). On CD3/CD21
plot of lymphocytes (plot A3), the 3 well-separated
populations CD21+, CD21–CD3–, and CD21–CD3+
were gated. The surface immunoglobulin G (sIgG+)
gates were placed on these 3 populations (plots B1,
B2, B3) as well as the 4 quadrant gates on CD4/CD8
plots (plots C1, C2, C3). The cells in each of the 3
major CD4/CD8 subsets of CD21 – CD3 + cells (plot
C3) were gated for γ δ TCR+ (plots D1, D2, D3) and
CD25+ (plots E1, E2, E3) cells.
Statistical Analysis. The JMP statistical software
(JMP 10, SAS Institute Inc., Cary, North Carolina,
U.S.A.) was used to analyze normal data distribu-
tion of each lymphocyte subset percentages. The
outliers were identified and eliminated before the
mean and standard deviation (SD) analysis.
Results
The gating strategy of canine lymphocyte immuno-
phenotyping is demonstrated graphically in Figure
1. The gating of each plot was adjusted in individ-
ual samples. All samples contained high numbers
of cells with high granularity (plot A2). The pheno-
types of individual lymphocyte populations and
their distributions, relative to their parent subsets
and the total lymphocytes, are summarized in Table
II. Minor lymphocyte subsets representing < 1% of
their parent subsets were not presented.
The averaged relative percentages of CD3+,
CD4+, CD8+, CD21+ and γ δ TCR+ from total lym-
phocytes were 74.0, 43.6, 14.3, 9.6, and 0.2, respec-
tively. The multiparameter flow cytometry analysis
showed a well-separated CD21+ population with
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Table I List of Primary Antibodies and Secondary Conjugates Used in this Study
Source Catalog #/clone Primary antibodies, dye Isotype Secondary antibodies, dye Source Catalog #
AbD Serotec MCA1774F Mouse anti-canine CD3, Mouse IgG1
CA17.2A12 FITCa
VMRD DH29A Mouse anti-canine CD4 Mouse IgM Goat anti-mouse IgM, Southern 1020-17
Phycoerythrin-Cy7 BioTech
AbD Serotec MCA1039A700 Rat anti-canine CD8α, Rat IgG1
YCATE55.9 Alexa Fluor 700a
AbD Serotec MCA1781PE Mouse anti-canine CD21, Mouse IgG1
CA2.1D6 Phycoerythrina
US Biological I1903-17B Goat anti-canine IgG (Fc), Goat PAbb Streptavidin-DyeMer Invitrogen S-32386
Biotin 488/615
UC Davis CA20.8H1 Mouse anti-canine γδ TCR Mouse IgG2a Goat anti-mouse IgG2a, Invitrogen M32218
Phycoerythrin-Cy5.5
eBioscience 50-0250-42 Mouse anti-canine CD25, Mouse IgG1
P4A10 eFluor 660a
aCommercially direct-conjugated.
bPolyclonal antibody.
Source list: AbD Serotec, Raleigh, North Carolina; eBioscience, San Diego, California; Invitrogen: Life Technologies Corporation, Carlsbad, California; 
SouthernBiotech: SouthernBiotechnology Associates Inc., Birmingham, Alabama; UC Davis: Dr. Peter Moore’s laboratory, University of California, Davis; 
US Biological: United State Biological, Salem, Massachusetts; and VMRD: Veterinary Medical Research and Development Inc., Pullman, Washington.
the majority of these cells also expressing CD3 fluo-
rescence (plot A3). Another 10.3% of the PBLs were
unidentified (CD21 – CD3 + CD4 – CD8 – γ δ TCR–).
The 2.9% of the CD21 – CD3 + CD4 + CD8 – γ δ TCR–
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Figure 1 Graphic gating
strategy of a representative
sample. Percentages of gated
population of the parent 
population (ﬁrst row of 
numbers) and of the total 
lymphocyte (A2) (second row
of numbers in B, C, D, and E)
are shown.
subset that expressed CD25 may represent regula-
tory T cells (Treg).
Discussion
The averaged percentages of CD3+, CD4+, CD8+,
CD21+ and γ δ TCR+ cells from the 26-week old
Beagles were 74.0, 43.6, 14.3, 9.6, and 0.2, which
were comparable to other reports. Faldyna et al4
studied fresh PBMCs of 12 adult Beagles using 
single color flow cytometry and reported their 
subset percentages at 88.1, 46.1, 21.8, 12.1, and 2.1,
respectively. Byrne et al1 studied lymphocyte sub-
set distribution also in Beagles using single color
flow cytometry. They reported percentages of
CD3+, CD4+, CD8+, and CD21+ at 79.5, 45.1, 17.0,
and 22.7 in 2-year-old dogs and 79.5, 30.9, 18.9, and
13.8 in 9-year-old dogs. Faldyna et al4 reported
changes in lymphocyte subset distribution in dif-
ferent age groups using single color flow cytome-
try. The study in 38 Beagles of 6 age groups (new-
born to > 5 years) found that the CD21+ percentage
decreased while the CD8+ percentage increased
with advancing age. The changes were more ap-
parent in the first year of age. There were no age-
related changes in CD4+ and γ δ TCR+ percentages,
so the CD4+/CD8+ ratio also decreased in older
dogs. Villaescusa et al10 performed a longitudinal
study of PBL subsets of the same 13 Beagle dogs
from 7–15 months of age using dual and triple color
flow cytometry and reported a decrease of lym-
phocyte, CD3+, CD3+CD4+ and CD21+ subsets 
but an increase of CD3+CD8+ lymphocytes with
increasing age. The findings were in agreement
with the earlier studies. The authors concluded that
the changes related to the maturation of lympho-
cyte subsets occurred during early life in Beagle
dogs.
The CD21 molecule or the complement receptor
(CR2) has been used to identify B cells, and the CD3
molecule has been used to identify T cells.1,4,7,10
The anti-canine CD21 and anti-canine CD3 mAbs
used in this study were from the anti-canine 
CD21 clone CA2.1D6 and anti-canine CD3 clone
CA17.2A12 from Dr. Peter Moore’s laboratory (Uni-
versity of California, Davis, U.S.A.). The companies
that market these antibodies (AbD Serotec, Raleigh,
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Table II Mean and Standard Deviation of Canine Lymphocyte Subset
% of parent % of total
population lymphocytes
Other
Plot CD21 CD3 CD4 CD8 markers Mean SD Mean SD Proposed phenotype included
A1 68.3 6.5 Single cells
A2 60.4 9.7 Lymphocytes
A3 CD21– CD3+ 74.0 6.4 All T cells
A3 CD21– CD3– 12.3 4.3
A3 CD21+ 9.6 2.6 All B cells
B1 CD21+ sIgG+ 15.2 4.0 1.5 0.5 IgG memory B cells
B1 CD21+ sIgG– 84.8 4.0 8.1 2.5 Virgin and non-IgG memory B cells
B2 CD21– CD3– sIgG+ 3.1 1.5 0.5 0.3
B2 CD21– CD3– sIgG– 96.9 1.5 12.8 5.5
B3 CD21– CD3+ sIgG+ 4.1 1.2 3.0 0.9
B3 CD21– CD3+ sIgG– 95.9 1.2 70.5 7.4 NK cells
C1 CD21+ CD4+ CD8– 6.0 2.2 0.5 0.2
C1 CD21+ CD4– CD8– 93.2 2.1 7.6 2.5
C2 CD21– CD3– CD4– CD8– 97.7 1.2 12.4 5.4 Non-adherent monocytes
C3 CD21– CD3+ CD4+ CD8– 61.9 4.9 43.4 6.0
C3 CD21– CD3+ CD4– CD8+ 21.1 4.1 14.5 3.9
C3 CD21– CD3+ CD4– CD8– 15.6 3.3 10.8 2.8
D1 CD21– CD3+ CD4+ CD8– γδ TCR– 99.9 0.0 43.6 6.3 T helper cells
D2 CD21– CD3+ CD4– CD8+ γδ TCR– 99.1 0.3 14.3 4.0 Cytotoxic T cells
D3 CD21– CD3+ CD4– CD8– γδ TCR+ 2.1 0.7 0.2 0.1 γδ TCR+ T cells
D3 CD21– CD3+ CD4– CD8– γδ TCR– 97.9 0.7 10.3 2.5 Unidentiﬁed T cells
E1 CD21– CD3+ CD4+ CD8– CD25+ 6.4 1.1 2.9 0.6 Treg
E2 CD21– CD3+ CD4– CD8+ CD25+ 1.1 0.3 0.2 0.1
E3 CD21– CD3+ CD4– CD8– CD25+ 12.7 2.6 1.4 0.4
SD = standard deviation.
North Carolina, U.S.A. and United States Biologi-
cal, Salem, Massachusetts) recommended that these
2 clones should not be used together in dual color
flow cytometry due to nonspecific interactions be-
tween the 2 reagents. Both companies confirmed
their recommendation when contacted but did not
disclose the nature of the interference. There were
other reports that studied the nonspecific interac-
tion between these same CD21/CD3 mAbs in ca-
nine PBMC by flow cytometry. Yagihara et al2 did
not observe any nonspecific interaction in their 
preliminary study. Villaescusa et al7 stained the
PBMCs from clinically normal German shepherd
(n = 11) and Labrador retriever (n = 12) dogs using
mAbs from the same CD3 and CD21 mAb clones.
The authors did not mention any nonspecific inter-
action of the 2 mAbs or the coexpression of the 2
markers but later10 stained Beagle dog PBMCs with
the same direct conjugated CD3-FITC and CD21-PE
mAb clones in 2 steps with an additional step of 
1% bovine serum albumin in PBS in between. The
multiparameter flow cytometry analysis in this
study showed a well-separated CD21+ population
with the majority of these cells also expressing CD3
fluorescence and could be interpreted as a nonspe-
cific interaction between the 2 antibodies (plot A3).
When the CD21+ population was further analyzed,
there were only a few cells that coexpressed the
CD4 marker (6.0% of CD21+ cells/0.5% of total
lymphocytes) but no substantial CD8+ or γ δ TCR
coexpression with CD21 (plot C1). The coexpres-
sion of CD21 and CD3 was reported in 29% of the
dogs of many different breeds (no Beagles) with
lymphoproliferative disorders characterized by
small-cell lymphocytosis.2 Wilkerson et al8 found
the same coexpression of these B and T cell markers
on canine lymphoma cells from 29 different dog
breeds. They concluded that the aberrant CD mole-
cule expression is not uncommon in canine lym-
phomas and can be used as diagnostic marker for
malignancy. They utilized the dual staining of these
2 mAb clones to diagnose canine B cell, T cell, or
mixed cell lymphoma from lymph node–derived
lymphocytes. We suggest that these 2 commonly
used CD21/CD3 mAb clones can and should be
used together with the proper steps of lymphocyte
identification gating during the flow data analysis.
If this FITC-conjugated CD3 mAb clone is used
without the CD21 mAb, the CD3+ cell gating may
include a substantial number of CD21+ cells. This
could contribute to the much higher averaged
CD3+ subset percentages in Beagle dogs reported
by Byrne et al1 and Faldyna et al.4 Both reports
stained PBMC with the same CD3 mAb clone as
used in this study and had FITC as the secondary
conjugate in a single color flow cytometry analysis.
They identified 79.5% and 88.1% CD3+ subset,
which was 5.5% and 14.1% higher than our results
from multicolor staining and analyzing by gating
CD3 together with CD21 marker.
This study and those of Byrne et al1 and Faldyna
et al4 used FITC as direct or secondary conjugate for
the CD3 marker. FITC has a similar range of fluo-
rescent spectrum as normal tissue endogenous au-
tofluorescence, which originates mainly from mito-
chondria and lysosomes.13 Vremec et al14 enriched
mouse dendritic cells and found up to 30% of auto-
fluorescent cells, which were brightest in PE and
FITC channels of flow cytometer. Mitchell et al15
found multiple sources of autofluorescence present
in most myeloid cells. Even though autofluores-
cence has not been mentioned as a significant prob-
lem in lymphoid cell research, it is possible that
FITC fluorescence detected in the canine CD21+
population may be due to endogenous autofluores-
cence rather than the nonspecific binding of the
CD3 mAb to CD21+ cells. In our unstained canine
PBMC control, 2.17% and 0.45% of the total lym-
phocytes expressed fluorescence in FITC and PE
channels, while almost no cell had any expression
in other channels (data not shown). Other choices 
of fluorochrome for CD3 and other canine CD3-
specific mAb clones should be screened to observe
whether they also detect CD3 fluorochrome on a
high percentage of CD21+ cells.
Our study detected only 0.2% of total lympho-
cytes that were γ δ TCR+ cells. Faldyna et al4 used
the same mAb to canine γ δ TCR which stained 2.1%
of the lymphocytes. However, the CD21–CD3+
CD4–CD8– γ δ TCR– subset represented 10.3% of 
all lymphocytes (plot D3), and 12.7% of those ex-
pressed CD25 (plot E3). These CD21–CD3+CD4–
CD8– γ δ TCR– cells remained unidentified. These
cells may be speculated to be γ δ TCR cells that did
not express the surface γ δ TCR antigen detectable
by the γ δ TCR mAb used in this study.
The polyclonal antibody (pAb) to canine IgG
stained 15.2% of CD21+ cells in this study. Coffman
and Cohn16 identified the B cells with IgG1 on their
surface as memory B cells, the precursors of IgG1
antibody producing cells, while the virgin B cells
had IgM and IgD on their surface. This memory B
cells marker helps differentiate IgG memory B cells
from virgin B cells and showed the ability of B cells
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to be primed either by vaccination or natural expo-
sure.
The CD21–CD3– (non-B, non-T) lymphocyte sub-
set possibly includes contaminating nonadherent
monocytes. This group of Beagle dogs had 12.3% 
of this lymphocyte subset similar to 12% reported 
in Labrador retriever and 17% in German shepherd
dogs.10 In the Beagle dogs study by Villaescusa et
al7 the PBMC without CD3 and CD21 cell markers
varied from approximately 16% at 7 months of age
and 21.5% 34 weeks later. The same cell population
percentages in their control adult Beagle dogs > 4
years of age in the same period of the study were
20.3% and 27.9%, respectively. The decrease in B
cell percentage in the blood by age may contribute
to the relative increase in this lymphocyte subset
percentage over time. Huang et al17 described ca-
nine killer NK cells as CD5lo with CD3+ and vary-
ing levels of CD8+. We did not include NK cell 
specific marker in this study and thus cannot ac-
curately identify the NK cell population.
The CD4+CD25+ population was identified as 
a part of the Treg phenotype in humans18,19 and
other animal species20-22 when coexpressed with
the transcription factor forkhead box P3 (FoxP3).
There was 2.9% of the CD21–CD3+CD4+CD8–
subset that expressed CD25 in the circulation of 
the dogs in this study (plot E1). We did not stain 
for FoxP3 antigen and thus cannot confirm wheth-
er they are part of the natural Treg. Daneshvar 
et al23 studied the alteration of canine mononu-
clear cell subpopulations after immunization with 
gentamicin-attenuated Leishmania infantum. They
identified CD4+CD25+ T cells in lymph node as
Treg, without using FoxP3 staining. Felix De Lima
et al24 reported that the reduction of the same 
phenotype of CD4+CD25+ Treg cells in lymph
nodes correlated with protection against leish-
maniasis.
This study did not include staining to exclude
dead cells due to the utilization of fresh cells,
stained within 6 hours of blood collection. The dead
cell staining would occupy a useful fluorochrome
channel of the flow cytometer and reduced the pos-
sible choices of important lymphocyte markers.
Conclusions
The novel multiparameter flow cytometry present-
ed here is a powerful tool to increase the accuracy of
lymphocyte phenotyping by simultaneously stain-
ing lymphocytes with specific antibodies to 6 B and
T cell markers, which made it possible to identify B
and T cell phenotypes and their distribution direct-
ly related to each other. Careful selection of com-
patible antibody/conjugate panel and instrument
compensation are necessary to obtain the optimum
signals for all fluorochromes used in the system.
Different antibody panels can be designed to define
more specific lymphocyte subsets and their func-
tions. The high number of dogs (n = 79) and number
of acquired cells from each sample (averaged
1.9 × 105 cells) in this study allowed the detection of
minor lymphocyte subsets in this group of dogs.
These results presented baseline normal canine
lymphocyte phenotypes. This report does not rep-
resent dogs of different breed, age group, or phy-
siological condition and should be interpreted ac-
cording to the materials and methods described.
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